Cargando…
Changes in systolic blood pressure in dogs with pituitary dependent hyperadrenocorticism during the first year of trilostane treatment
BACKGROUND: Systemic hypertension (SH) is common in dogs and humans with hypercortisolism and can persist after treatment. OBJECTIVES: To evaluate changes in prevalence of SH and systolic blood pressure (SBP) in dogs with pituitary‐dependent hyperadrenocorticism (PDH) during the first year of trilos...
Autores principales: | García San José, Paula, Arenas Bermejo, Carolina, Alonso‐Miguel, Daniel, Clares Moral, Irene, Cuesta‐Alvaro, Pedro, Pérez Alenza, María Dolores |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848348/ https://www.ncbi.nlm.nih.gov/pubmed/33274787 http://dx.doi.org/10.1111/jvim.15978 |
Ejemplares similares
-
Laboratory assessment of trilostane treatment in dogs with pituitary‐dependent hyperadrenocorticism
por: Arenas Bermejo, Carolina, et al.
Publicado: (2020) -
Prevalence and risk factors associated with systemic hypertension in dogs with spontaneous hyperadrenocorticism
por: García San José, Paula, et al.
Publicado: (2020) -
Cortisol Concentrations in Well‐Regulated Dogs with Hyperadrenocorticism Treated with Trilostane
por: Midence, J.N., et al.
Publicado: (2015) -
Evaluation of compounded trilostane packets for dogs with naturally occurring hyperadrenocorticism
por: Nam, Sookin, et al.
Publicado: (2021) -
Comparison of Survival Times for Dogs with Pituitary‐Dependent Hyperadrenocorticism in a Primary‐Care Hospital: Treated with Trilostane versus Untreated
por: Nagata, N., et al.
Publicado: (2016)